Table 2 Clinical characteristics of patients.

From: Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer

 

No.

%

Age (years;<median/≥median)

 <61

9

24,30

 ≥61

28

75,70

Recurrence/Progression

 No

8

21,60%

 Yes

29

78,40%

Grading

 I

2

6,10%

 II

1

3,00%

 III

30

90,90%

FIGO Stage

 I - II

4

13,30%

 III-IV

26

86,70%

Histotype

 Clear Cell

6

16,70%

 Endometrioid

2

5,60%

 Mucinous

1

2,80%

 Serous

24

66,70%

 Small Cell

1

2,80%

 Undifferetiated

2

5,60%

Survival status

 AWD

9

25,00%

 DOD

16

44,40%

 NED

11

30,60%

Treatment Response

 NA

8

27,60%

 PD

3

10,30%

 CR

13

44,80%

 PR

5

17,20%

  1. AWD: Alive with Disease; DOD: Died of Disease; NED: No Evidence of (Active) Disease; PD: Progressive Disease; PR: Partial Response; CR: Complete Response; NA: Not Assessable.
Back to article page